1-Alkyl-2-nitroimidazol-5-yl derivatives.  I.
D000818:Animals; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000138:chemical synthesis*; D002176:Candida albicans / Q000187:drug effects; D003016:Clostridium perfringens / Q000187:drug effects; D004926:Escherichia coli / Q000187:drug effects; D004927:Escherichia coli Infections / Q000188:drug therapy; D066298:In Vitro Techniques; D007711:Klebsiella pneumoniae / Q000187:drug effects; D007928:Lethal Dose 50; D051379:Mice; D008826:Microbial Sensitivity Tests; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009174:Mycoplasma / Q000187:drug effects; D009582:Nitrofurantoin / Q000494:pharmacology; D009593:Nitroimidazoles / Q000138:chemical synthesis* / Q000494:pharmacology / Q000627:therapeutic use; D012486:Salmonella typhimurium / Q000187:drug effects; D012764:Shigella sonnei / Q000187:drug effects; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013291:Streptococcus / Q000187:drug effects; D013296:Streptococcus pneumoniae / Q000187:drug effects; D014246:Trichomonas vaginalis / Q000187:drug effects; D014249:Trichophyton / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D009593:Nitroimidazoles; D009582:Nitrofurantoin